A Survey of Population Pharmacokinetic Reports Submitted to the USFDA: An Analysis of Common Issues in NDA and BLA from 2012 to 2021
ConclusionThe findings from this study may help the applicant understand the FDA ’s thinking on the PopPK analysis.
Source: Clinical Pharmacokinetics - Category: Drugs & Pharmacology Source Type: research